Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for CGEM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -1.10M
March 31, 2026 -0.38M
December 31, 2025 -0.715M
September 30, 2025 0.00
June 30, 2025 -0.373M
March 31, 2025 0.00
December 31, 2024 -1.582M
September 30, 2024 -1.981M
June 30, 2024 -265.99M
March 31, 2024 -1.085M
December 31, 2023 -0.248M
September 30, 2023 -0.29M
June 30, 2023 -38.39M
March 31, 2023 0.00
Date Value
December 31, 2022 -2.569M
September 30, 2022 -1.425M
June 30, 2022 -2.813M
March 31, 2022 -1.588M
December 31, 2021 -2.702M
September 30, 2021 -0.579M
June 30, 2021 0.00
March 31, 2021 -264.58M
December 31, 2020 -124.90M
September 30, 2020 -1.206M
June 30, 2020 0.00
March 31, 2020 -14.04M
December 31, 2019 -83.91M
September 30, 2019 0.00

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Rallybio Corp. -0.131M
MapLight Therapeutics, Inc. -0.092M
Arrowhead Pharmaceuticals, Inc. -29.86M
Oncolytics Biotech, Inc. -6.704M
Sangamo Therapeutics, Inc. -27.08M